Image

Improving Nutritional Adequacy of ICU Survivors in a Prospective Interventional Way: the Bright Side Study

Improving Nutritional Adequacy of ICU Survivors in a Prospective Interventional Way: the Bright Side Study

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The objective is to increase caloric adequacy in patients who survived critical illness and are admitted to the ward by the use of a pro-active inclusive nutritional strategy including supplemental parenteral and/or enteral nutrition and/or oral nutritional supplements guided by indirect calorimetry.

This enables the investigators to address, within a clinical/scientific context, a recently demonstrated but until now relatively neglected 'dark side' of patient care at UZ Brussel, comparable to limited global evidence : iatrogenic malnutrition of ICU survivors. The use of a newly developed clinical pathway and nutrition strategy (oral, enteral and parenteral) led by a single SPoC (Single Point of Contact) for patients surviving intensive care will have a clear objective: to address the nutritional deficit in all patients.

Eligibility

Inclusion Criteria:

  • Adult ≥ 18 years
  • ICU stay ≥ 7 days
  • Ward stay ≥ 3 days
  • Nutritional therapy not restricted
  • Heterogeneous diseases

Exclusion Criteria:

  • Patients < 18 years
  • ICU < 7 days
  • Ward stay < 3 days
  • Advanced Care Planning with impact on nutritional therapy
  • Patients with palliative care
  • Metabolic derangements such as metabolic diseases
  • Pregnancy

Study details
    Malnutrition

NCT06023251

Universitair Ziekenhuis Brussel

16 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.